$5.95
-0.1-1.65%
At close: -
$5.95
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Enanta Pharma Insider Trading Activity | NASDAQ:ENTA | Benzinga
Track the latest Enanta Pharma insider trading activity. Stay informed on recent buys, sells, and market impact for Enanta Pharma stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Enanta Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 12, 2025, Jay Luly, the company's PRESIDENT AND CEO purchased 45K shares for $5.69 each.
Ownership Statistics for Enanta Pharmaceuticals Inc
Shares Outstanding
21.333M
Insider Shares Owned
1.590M
Insider Percentage Owned
7.45%
Institutional Shares Held
6.314M
Institutional Percentage Held
29.6%
| Feb 12, 2025 | Jay Luly | PRESIDENT AND CEO | 45.00K | $5.69 | $256.05K | BUY | 5.61% | 846.64K | Feb 12 | View |
| Dec 10, 2024 | Lynn Tara Kieffer | CHIEF PRODUCT STRATEGY OFFICER | -2.28K | $8.06 | -$18.40K | SELL | -7.23% | 29.30K | Dec 06 | View |
| Dec 10, 2024 | Brendan Luu | CHIEF BUSINESS OFFICER | -2.28K | $8.06 | -$18.40K | SELL | -5.96% | 36.05K | Dec 06 | View |
| Dec 10, 2024 | Scott Rottinghaus | CHIEF MEDICAL OFFICER | -866.00 | $8.06 | -$6.98K | SELL | -4.61% | 17.92K | Dec 06 | View |
| Dec 10, 2024 | Matthew Kowalsky as attorney-in-fact | CHIEF SCIENTIFIC OFFICER | -2.59K | $8.06 | -$20.88K | SELL | -0.70% | 369.11K | Dec 06 | View |
| Dec 10, 2024 | PAUL MELLETT | CHIEF FIN. & ADMIN OFFICER | -2.59K | $8.06 | -$20.88K | SELL | -2.75% | 91.71K | Dec 06 | View |
| Dec 10, 2024 | Jay Luly | PRESIDENT AND CEO | -5.14K | $8.06 | -$41.44K | SELL | -0.64% | 801.64K | Dec 06 | View |
| Jul 15, 2024 | Scott Rottinghaus | CHIEF MEDICAL OFFICER | -6.57K | $12.48 | -$142.43K | SELL | -23.23% | 21.72K | Jul 11 - Jul 15 | View |
| Jun 17, 2024 | Lynn Tara Kieffer | CHIEF PRODUCT STRATEGY OFFICER | -7.27K | $12.33 | -$89.59K | SELL | -18.35% | 32.34K | Jun 17 | View |
| Dec 15, 2023 | Terry Vance | DIRECTOR | -15.29K | $9.12 | -$139.49K | SELL | -72.51% | 5.80K | Dec 13 | View |
| Dec 06, 2023 | Brendan Luu | SR. VP, BUSINESS DEV. | -2.13K | $9.63 | -$20.46K | SELL | -5.47% | 36.74K | Dec 05 | View |
| Dec 06, 2023 | Lynn Tara Kieffer | SR. VP, NEW PROD. STRAT. & DEV | -2.13K | $9.63 | -$20.46K | SELL | -5.40% | 37.26K | Dec 05 | View |
| Dec 06, 2023 | Nathaniel S Gardiner | SR. VP & GENERAL COUNSEL | -2.41K | $9.63 | -$23.23K | SELL | -2.26% | 104.08K | Dec 05 | View |
| Dec 06, 2023 | Scott Rottinghaus | SR. VP & CMO | -534.00 | $9.63 | -$5.14K | SELL | -1.98% | 26.47K | Dec 05 | View |
| Dec 06, 2023 | Nathaniel S. Gardiner as attorney-in-fact | SR. VP, R&D & CSO | -2.41K | $9.63 | -$23.23K | SELL | -0.65% | 370.69K | Dec 05 | View |
| Dec 06, 2023 | PAUL MELLETT | SR. VP, FINANCE & ADMIN. & CFO | -2.41K | $9.63 | -$23.23K | SELL | -2.51% | 93.55K | Dec 05 | View |
| Dec 06, 2023 | Jay Luly | PRESIDENT AND CEO | -7.23K | $9.63 | -$69.62K | SELL | -0.89% | 806.79K | Dec 05 | View |
| Mar 17, 2023 | PAUL MELLETT | TREASURER AND CFO | 0.00 | $29.21 | -$317.64K | SELL-OPTIONS | 0.00% | 97.56K | Mar 15 | View |
| Mar 17, 2023 | Nathaniel S. Gardiner as attorney-in-fact | SR. VP & CSO | 0.00 | $29.22 | -$424.01K | SELL-OPTIONS | 0.00% | 374.70K | Mar 15 | View |
| Mar 14, 2023 | Jay Luly | PRESIDENT AND CEO | 0.00 | $29.58 | -$869.86K | SELL-OPTIONS | 0.00% | 819.81K | Mar 13 | View |
| Feb 13, 2023 | PAUL MELLETT | TREASURER AND CFO | -5.00K | $53.76 | -$268.82K | SELL | -5.65% | 83.46K | Feb 09 | View |
| Dec 16, 2022 | Jay Luly | PRESIDENT AND CEO | 0.00 | $29.41 | -$918.81K | SELL-OPTIONS | 0.00% | 773.80K | Dec 16 | View |
| Apr 05, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $56.12 | -$2.58M | SELL-OPTIONS | 0.00% | 34.98K | Apr 01 - Apr 04 | View |
| Mar 22, 2022 | BRUCE CARTER | DIRECTOR | 0.00 | $46.70 | -$253.49K | SELL-OPTIONS | 0.00% | 0.00 | Mar 21 | View |
| Mar 03, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $56.83 | -$984.48K | SELL-OPTIONS | 0.00% | 34.98K | Mar 01 - Mar 02 | View |
| Jan 13, 2022 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $55.00 | -$379.24K | SELL-OPTIONS | 0.00% | 32.90K | Jan 11 | View |
| Dec 03, 2021 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | -842.00 | $65.84 | -$629.66K | SELL | -2.50% | 32.90K | Dec 01 | View |
| Nov 02, 2021 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $66.70 | -$347.20K | SELL-OPTIONS | 0.00% | 26.94K | Nov 01 | View |
| Oct 13, 2021 | Nathalie Adda | SR. VP & CHIEF MEDICAL OFFICER | 0.00 | $56.80 | -$467.07K | SELL-OPTIONS | 0.00% | 26.94K | Oct 08 - Oct 11 | View |
| Sep 17, 2021 | Jay Luly | PRESIDENT AND CEO | -4.52K | $59.06 | -$266.70K | SELL | -0.66% | 676.97K | Sep 15 | View |
| Jan 08, 2021 | PAUL MELLETT | TREASURER AND CFO | -6.00K | $45.58 | -$273.46K | SELL | -8.85% | 61.76K | Jan 08 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
